Schedule 13G ownership disclosure

LA JOLLA PHARMACEUTICAL CO

Security class unavailable · CUSIP: 503459604

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,407,371
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001137774-18-000014
Form type
SC 13G/A
Filer
LA JOLLA PHARMACEUTICAL CO
CIK
CIK 920465
Filed
Jan 26, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub